A Real-World Cohort Study of EGFR TKIs in Patients with NSCLC with Uncommon EGFR mutations (UpSwinG)

被引：2

作者：

Miura, S. ^{[1
]}

Hsia, T. ^{[2
]}

Hung, J. ^{[3
]}

Jung, H. A. ^{[4
]}

Shih, J. ^{[5
]}

Park, C. ^{[6
,7
]}

Lee, S. H. ^{[8
]}

Okamoto, T. ^{[9
]}

Ahn, H. K. ^{[10
]}

Lee, Y. C. ^{[11
]}

Sato, Y. ^{[12
]}

Lee, S. S. ^{[13
]}

Mascaux, C. ^{[14
]}

Daoud, H. ^{[15
]}

Maerten, A. ^{[15
]}

Popat, S. ^{[16
,17
]}

机构：

[1] Niigata Canc Ctr Hosp, Dept Internal Med, Niigata, Japan

[2] China Med Univ, Dept Resp Therapy, Dept Internal Med, China Med Univ Hosp, Taichung, Taiwan

[3] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Kaohsiung, Taiwan

[4] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea

[5] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan

[6] Chonnam Natl Univ, Sch Med, Dept Internal Med, Hwasun, South Korea

[7] Hwasun Hosp, Hwasun, South Korea

[8] Kyung Hee Univ, Sch Med, Div Pulm & Crit Care Med, Dept Internal Med,Med Ctr, Seoul, South Korea

[9] Natl Hosp Org Kyushu Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan

[10] Gachon Univ, Gil Med Ctr, Div Med Oncol, Incheon, South Korea

[11] Chonbuk Natl Univ, Res Inst Clin Med, Biomed Res Inst, Dept Internal Med,Chonbuk Natl Univ Hosp,Med Sch, Jeonju, South Korea

[12] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo, Japan

[13] Inje Univ, Coll Med, Haeundae Paik Hosp, Busan, South Korea

[14] Strasbourg Univ, Strasbourg Univ Hosp, Dept Pulm, Strasbourg, France

[15] Boehringer Ingelheim Int Gmbh, Ingelheim, Germany

[16] Royal Marsden Natl Hlth Serv Fdn Trust, Lung Unit, London, England

[17] Inst Canc Res, London, England

来源：

JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期

关键词：

D O I：

10.1016/j.jtho.2021.08.531

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P50.03

引用

页码：S1115 / S1116

页数：2

共 50 条

[21] The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study [J].

Yu, Xiaoqing ;

Si, Jinfei ;

Wei, Jingwen ;

Wang, Yanling ;

Sun, Yan ;

Jin, Jianan ;

Zhang, Xiaoyan ;

Ma, Tonghui ;

Song, Zhengbo .

CANCER MEDICINE, 2023, 12 (05) :5630-5638

[22] Real-world long-term outcomes of advanced/metastatic NSCLC patients treated with EGFR TKIs in Nottinghamshire [J].

Lopez-Escola, C. ;

Mengoli, K. ;

Sheikh, O. ;

Karim, S. ;

Sadiq, M. .

LUNG CANCER, 2020, 139 :S62-S62

[23] Real-world response and outcomes in NSCLC patients with EGFR exon 20 insertion mutations. [J].

Ou, Sai-Hong Ignatius ;

Lin, Huamao Mark ;

Hong, Jin-Liern ;

Yin, Yu ;

Jin, Shu ;

Lin, Jianchang ;

Mehta, Minal ;

Nguyen, Danny ;

Neal, Joel W. .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

[24] Real-World Characteristics and Outcomes of Advanced NSCLC Patients with Exon 19 or 21 EGFR Mutations [J].

Winfree, K. ;

Molife, C. ;

Peterson, P. ;

Chen, Y. ;

Visseren, C. ;

Beyrer, J. ;

Leusch, M. ;

Dimou, A. .

JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) :S23-S23

[25] Monitoring Plasma EGFR Mutations during First Line Treatment with EGFR TKIs in NSCLC Patients [J].

Mohorcic, Katja ;

Kern, Izidor ;

Janzic, Urska ;

Hitij, Nina Turnsek ;

Rot, Mitja ;

Cufer, Tanja .

JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) :S388-S389

[26] Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patients [J].

Xiong, Liwen ;

Cui, Shaohua ;

Ding, Jingyan ;

Sun, Yun ;

Zhang, Longfu ;

Zhao, Yizhuo ;

Gu, Aiqin ;

Chu, Tianqing ;

Wang, Huimin ;

Zhong, Hua ;

Ye, Xin ;

Gu, Yi ;

Zhang, Xin ;

Hu, Min ;

Jiang, Liyan .

ONCOTARGET, 2017, 8 (38) :63846-63856

[27] FURTHER: A global study to evaluate furmonertinib in patients with EGFR mutant NSCLC including uncommon EGFR mutations [J].

Le, Xiuning ;

Spira, Alexander ;

Gadgeel, Shirish ;

Yu, Yan ;

Zhao, Yanqiu ;

Cheng, Ying ;

Riess, Jonathan ;

Juan-Vidal, Oscar ;

Gao, Bo ;

Yoh, Kiyotaka ;

Forster, Martin ;

Kitazono, Satoru ;

Hayashi, Hidetoshi ;

Planchard, David ;

Jiang, Yong ;

Huang, Jack ;

Baio, Nichole ;

Kowanetz, Marcin ;

Wang, Shirley ;

Leung, William ;

Hsu, Jerry Y. ;

Wang, Jie .

CANCER RESEARCH, 2024, 84 (07)

[28] Afatinib in patients with EGFR mutation-positive (EGFRm plus ) NSCLC harbouring uncommon mutations: Experience in 'Real-World' clinical practice [J].

Maerten, Angela ;

Brueckl, Wolfgang ;

Laack, Eckhart ;

Hoffmann, Christopher ;

Zhou, Caicun ;

Wu, Yi-Long .

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 :160-160

[29] No, EGFR TKIs Should Be Reserved for Patients With EGFR Mutations [J].

Riely, Gregory J. .

CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (01) :41-+

[30] Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations [J].

Wei, Zhigang ;

Ye, Xin ;

Yang, Xia ;

Zheng, Aimin ;

Huang, Guanghui ;

Li, Wenhong ;

Wang, Jiao ;

Han, Xiaoying ;

Meng, Min ;

Ni, Yang .

ONCOTARGET, 2017, 8 (34) :56714-56725

← 1 2 3 4 5 →